← 返回

TIL(肿瘤浸润淋巴细胞):结直肠癌中淋巴细胞浸润的特征与预后

英文原题:Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.

查看英文原题

Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.

PubMed 2022/06/01(内容时间) Bioengineered

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

TIL(肿瘤浸润淋巴细胞)(TILs)是肿瘤微环境(TME)的重要组成部分,TILs对结直肠癌(CRC)的抗肿瘤活性一直是人们关注的话题。

然而,CRC中各种类型淋巴细胞浸润的特征和预后尚未得到充分阐明。我们的研究旨在识别TILs的独特特征和预后。我们整合了多个队列数据库,以阐明TILs在CRC中的特征、比例和预后。

我们发现巨噬细胞在CRC中显著富集。当我们使用scRNA-seq数据库进一步评估TILs的比例时,我们注意到在四个Gene Expression Omnibus Series(GSE)CRC队列中,CD4+ T细胞、B细胞和CD8+ T细胞的数量显著更高。有趣的是,我们发现TIL亚群的浸润水平从高到低始终是树突状细胞、CD8+ T细胞、CD4+ T细胞、中性粒细胞、B细胞和巨噬细胞;无论特定基因突变或体细胞拷贝数变异(sCNV)如何,浸润比例基本恒定。

此外,数据证实CD4+ TILs和CD8+ TILs在CRC预后中具有一定的应用价值,并且年龄与CD8+ TILs和B细胞浆细胞浸润呈负相关。

最后,年龄超过70岁的CRC患者对免疫检查点阻断有更好的应答。

展开英文摘要原文

Tumor-infiltrating lymphocytes (TILs) are vital elements of the tumor microenvironment (TME), and the anti-tumor activity of TILs on colorectal cancer (CRC) has been a topic of concern.

However, the characteristics and prognosis of the various types of lymphocyte infiltration in CRC have not been fully explained.

Our study aimed to identify distinct features and prognosis of TILs.

We integrated multiple-cohort databases to illustrate the features, proportions, and prognosis of TILs on CRC.

We found that macrophages were significantly enriched in CRC. When we used the scRNA-seq database to further evaluate the proportion of TILs, we noticed markedly higher numbers of CD4 + T cell, B cell, and CD8 + T cell in four Gene Expression Omnibus Series (GSE) CRC cohorts.

Interestingly, we found that the infiltrating level of TIL subgroups from highest to lowest is always dendritic cells, CD8 + T cells, CD4 + T cells, neutrophils, B cells, and macrophages; the proportion of infiltration is largely constant regardless of mutations in specific genes or somatic copy number variation (sCNV).

In addition, the data corroborated that CD4+ TILs and CD8+ TILs have certain application values in the prognosis of CRCs, and age negatively related to CD8+ TILs and B plasma infiltration.

Finally, patients with CRC who are older than 70 years have a better response to immune-checkpoint blockade.

论文信息

作者
Qin M、Chen G、Hou J、Wang L、Wang Q、Wang L、Jiang D、Hu Y
第一作者单位
Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.China
通讯作者单位
Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, School of Medical Technology, Institute of Clinical Laboratory, Guangdong Medical University, Dongguan, China.China
期刊
Bioengineered2022 Jun
原文标识
PubMed 36633318 · DOI 10.1080/21655979.2022.2162660